3. LAIDMAN J. Anaphylaxis requires prompt epinephrine shot. Medscape Medical News [serial online]. December 3, 2014; Accessed December 6, 2014. Available at http://www.medscape.com/viewarticle/835786.
4. CAMPBELL RL, LI JT, NICKLAS RA, SADOSTY AT. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. Dec. 2014; 113(6):599-608.
7. AMERICAN HEART ASSOCIATION. GUIDELINES FOR CARDIOPULMONARY RESUSCITATION AND EMERGENCY CARDIOVASCULAR CARE: PART 10.6: Anaphylaxis. Circulation 2005; 112:143-5.
10. ACUTE CARE UNDERGRADUATE TEACHING (ACUTE) INITIATIVE. A joint publication from the Resuscitation Council (UK) and Intercollegiate Board for Training in Intensive Care Medicine. 2005.
12. NURMATOV U, WORTH A, SHEIKH A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol. Aug. 2008; 122(2):353-61, 361.e1-3.
13. LIEBERMAN P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol. Aug. 2003; 3(4):313-8.10.1097/00130832-200308000-00013
14. KEMP SF, LOCKEY RF, SIMONS FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. Aug. 2008; 63(8):1061-70.
15. SHEIKH A, SHEHATA YA, BROWN SGA, SIMONS FER. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Data Syst Rev 2008; 4:CD006312, doi:10.1002/14651858.CD006312.pub2
16. BRAGANZA SC, ACWORTH JP, MCKINNON DR, PEAKE JE, BROWN AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child. Feb. 2006; 91(2):159-63.
22. JOHANSSON SG, BIEBER T, DAHL R, FRIEDMANN PS, LANIER BQ, LOCKEY RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. May 2004; 113(5):832-6.
26. KEMP SF. Current concepts in pathophysiology, diagnosis, and management of anaphylaxis. Immunol Allergy Clin North Am 2001; 21:611-63410.1016/S0889-8561(15)30004-7
27. VADAS P, GOLD M, PERELMAN B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. Jan. 3 2008; 358(1):28-35.
28. NEUGUT AI, GHATAK AT, MILLER RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161:15-21.10.1001/archinte.161.1.15
29. YOCUM MW, KHAN DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994; 69:16-23.10.1016/S0025-6196(12)61606-1
30. DECKER WW, CAMPBELL RL, MANIVANNAN V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. Dec. 2008; 122(6):1161-5.
34. HOURIHANE JO'B, KILBURN SA, NORDLEE JA, HEFLE SL, TAYLOR SL, WARNER JO. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol. Nov. 1997; 100(5):596-600.
35. BOYCE JA, ASSA'AD A, BURKS AW, JONES SM, SAMPSON HA, WOOD RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. Dec. 2010; 126(6 Suppl):S1-58.10.1016/j.jaci.2010.10.007424196421134576
37. RUEFF F, PRZYBILLA B, BILO MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. Nov. 2009; 124(5):1047-54.
38. TORRES MJ, BLANCA M, FERNANDEZ J, et al, ENDA; EAACI Interest Group on Drug Hypersensitivity. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972.10.1034/j.1398-9995.2003.00280.x14510712
39. JOHNSON K. Antibiotics common cause of perioperative anaphylaxis. Medscape Medical News [serial online]. November 22, 2013; Accessed December 3, 2013. Available at http://www.medscape.com/viewarticle/814903.
41. PICHICHERO ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. Apr. 2005; 115(4):1048-57.10.1542/peds.2004-127615805383
42. DEMOLY P, ROMANO A, BOTELHO C, et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy. 2010; 65:327-332.10.1111/j.1398-9995.2009.02228.x19860790
49. LEE S, HESS EP, NESTLER DM, BELLAMKONDA ATHMARAM VR, BELLOLIO MF, DECKER WW, et al. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis. J Allergy Clin Immunol. Apr. 2013; 131(4):1103-8.
51. KATAYAMA H, YAMAGUCHI K, KOZUKA T, TAKASHIMA T, SEEZ P, MATSUURA K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.Radiology. Jun. 1990; 175(3):621-8.
52. GREENBERGER PA, PATTERSON R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. Apr. 1991; 87(4):867-72.
54. KEMP SF. The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms? Curr Allergy Asthma Rep. Mar. 2008; 8(1):45-8.
56. LIEBERMAN PL. Specific and idiopathic anaphylaxis: pathophysiology and treatment. In: Bierman CW, Pearlman DS, Shapiro GG, et al., eds. Allergy, Asthma and Immunology From Infancy to Adulthood. Third edition. Philadelphia, WB Saunders, 1996, pp. 297-319.
58. MONERET-VAUTRIN DA, MORISSET M, FLABBEE J, BEAUDOUIN E, KANNY G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. Apr. 2005; 60(4):443-51.
60. JOSE R, CLESHAM GJ. Survey of the use of epinephrine (adrenaline) for anaphylaxis by junior hospital doctors. Postgrad Med J 2007; 83:610-1.10.1136/pgmj.2007.059097260000917823230